Income Statement

v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Revenues:        
Sublicense revenue $ 0 $ 1,250,000 $ 0 $ 1,250,000
Total revenues 0 1,250,000 0 1,250,000
Operating expenses:        
Research and development 1,601,800 1,611,000 5,124,600 4,042,800
General and administrative 1,266,000 2,276,600 4,997,400 4,907,800
Total operating expenses 2,867,800 3,887,600 10,122,000 8,950,600
Loss from operations (2,867,800) (2,637,600) (10,122,000) (7,700,600)
Other expenses, net:        
Interest expense, net (2,000) (900) (7,700) (3,700)
Loss on extinguishment of accounts payable (135,000) 0 (135,000) 0
Loss before income taxes (3,004,800) (2,638,500) (10,264,700) (7,704,300)
Income taxes 0 0 (2,400) (2,400)
Net loss and comprehensive loss (3,004,800) (2,638,500) (10,267,100) (7,706,700)
Accrued dividends on Series B Preferred stock (263,000) (237,700) (766,600) (1,018,500)
Deemed dividend from trigger of down round provision feature (199,200) 0 (199,200) 0
Deemed dividend on Series B Preferred Units 0 0 0 (111,100)
Net loss attributable to common stockholders $ (3,467,000) $ (2,876,200) $ (11,232,900) $ (8,836,300)
Basic and diluted net loss attributable to common stockholders per common share $ (0.25) $ (0.34) $ (1.03) $ (1.23)
Weighted average shares used in computing basic and diluted net loss attributable to common stockholders per common share 13,895,642 8,381,824 10,947,556 7,181,307

Source